Megasphaera

Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 | Emergen Research

Retrieved on: 
Tuesday, January 17, 2023
National Association Medical Staff Services, Megasphaera, Honeywell, German Diabetes Center, World Health Organization, Kidney disease, DDZ, Temperature, National Center for Biotechnology Information, COVID-19, WHO, Blood pressure, GE Healthcare, Sinusitis, Health, Risk, Conditional sentence, Growth, Intel, National Center for Health Research, Prevalence, Diabetes, Masimo, Patient, Research, Cancer, Stroke, Kidney, Incidence, USD, Atherosclerosis, Pharmaceutical industry, Medtronic, Biotronik

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .
  • The patient monitoring devices market is expected to register a CAGR of 7.8% over the forecast period and revenue is projected to increase from USD 47.00 Billion in 2021 to USD 92.40 Billion in 2030. is expected to support revenue growth of the market.
  • The major factors for market expansion are the incidence of chronic diseases, favorable reimbursement circumstances, and rising awareness of patient monitoring devices.
  • Given the increasing research and development efforts by global market players to produce cutting-edge patient monitoring devices, the market revenue is expected to grow.

Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 | Emergen Research

Retrieved on: 
Tuesday, January 17, 2023
National Association Medical Staff Services, Megasphaera, Honeywell, German Diabetes Center, World Health Organization, Kidney disease, DDZ, Temperature, National Center for Biotechnology Information, COVID-19, WHO, Blood pressure, GE Healthcare, Sinusitis, Health, Risk, Conditional sentence, Growth, Intel, National Center for Health Research, Prevalence, Diabetes, Masimo, Patient, Research, Cancer, Stroke, Kidney, Incidence, USD, Atherosclerosis, Pharmaceutical industry, Medtronic, Biotronik

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .
  • The patient monitoring devices market is expected to register a CAGR of 7.8% over the forecast period and revenue is projected to increase from USD 47.00 Billion in 2021 to USD 92.40 Billion in 2030. is expected to support revenue growth of the market.
  • The major factors for market expansion are the incidence of chronic diseases, favorable reimbursement circumstances, and rising awareness of patient monitoring devices.
  • Given the increasing research and development efforts by global market players to produce cutting-edge patient monitoring devices, the market revenue is expected to grow.

Global Fitness Equipment Market Report 2022 to 2028 - Featuring Acme Fitness, Fitness World, Peloton Interactive and Technogym Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Fitness & Nutrition, Health, Megasphaera, Habit, National Center for Biotechnology Information, COVID-19, Conditional sentence, Death, Growth, National Center for Medical Readiness, Patient, Prevalence, Fitness, CVD, Coronary artery disease, Pharmaceutical industry

The global fitness equipment market is anticipated to grow at a substantial CAGR of 3.4 % during the forecast period.

Key Points: 
  • The global fitness equipment market is anticipated to grow at a substantial CAGR of 3.4 % during the forecast period.
  • The increasing number of chronic diseases across the globe due to unhealthy lifestyles and routines is rising need for fitness equipment market.
  • The global fitness equipment market is segmented based on the type and end-user.
  • Geographically the global fitness equipment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.

Global Lysosomal Disease Treatment Market Report 2022 to 2028: Featuring Pfizer, Takeda Pharmaceutical, Sanofi and Novartis Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 10, 2023
Biotechnology, Pharmaceutical, Genetics, Health, Megasphaera, Cell, Lipid, Tissue, National Center for Biotechnology Information, Enzyme replacement therapy, Fabry disease, Government, Type, LSD, Gene, Glycoprotein, Drug development, Diagnosis, Acceleration, National Center for Regenerative Medicine, Prevalence, Radiation, Bone marrow, Disease, Glycogen, Research, Male, Enzyme, Incidence, Glycogen storage disease, Gaucher's disease, Forest Law Enforcement and Governance Program, Pharmaceutical industry, Fabry, Mucopolysaccharidosis

The Global Lysosomal Disease Treatment Market size is expected to reach $11 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Key Points: 
  • The Global Lysosomal Disease Treatment Market size is expected to reach $11 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.
  • Lysosomal diseases (LSDs) are a complex group of metabolic disorders that are often inherited in an autosomal recessive manner.
  • The primary driving forces in the enzyme replacement therapy market are the expanding research and development for lysosomal disease diagnosis and drug development for treatment.
  • The increasing incidence of lysosomal disease will be a key factor contributing to the acceleration of the market's growth rate.

Mars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care

Retrieved on: 
Monday, January 9, 2023
Sequence, Cancer, Cat, Partnership, Broad, MIT, Megasphaera, Veterinarian, Mars, Incorporated, University of Massachusetts, Pet, Research, National Center for Biotechnology Information, PETS, Science, Genomics, Broad Institute, Dog, Disease, Waltham Petcare Science Institute, Harvard University, Health, Obesity, Ageing, Publishing, NCBI, Genetics, Medical imaging, Animal, Vaccine, Mars

Genomes from 10,000 dogs and 10,000 cats enrolled in the MARS PETCARE BIOBANK ™ initiative will be sequenced over the next 10 years.

Key Points: 
  • Genomes from 10,000 dogs and 10,000 cats enrolled in the MARS PETCARE BIOBANK ™ initiative will be sequenced over the next 10 years.
  • Insights from the open access database can help advance individualized pet health care for future generations of dogs and cats.
  • Mars Petcare scientists will be analyzing data and publishing initial results for the scientific community throughout 2023 and beyond.
  • "Our latest initiative with the Broad Institute is hugely exciting when it comes to advancing preventive pet care.

Mars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care

Retrieved on: 
Monday, January 9, 2023
Sequence, Cancer, Cat, Partnership, Broad, MIT, Megasphaera, Veterinarian, University of Massachusetts, Mars, Incorporated, Pet, Research, National Center for Biotechnology Information, PETS, Science, Genomics, Broad Institute, Dog, Disease, Waltham Petcare Science Institute, Harvard University, Health, Mars, Obesity, Ageing, Publishing, NCBI, Genetics, Medical imaging, Animal, Vaccine

Genomes from 10,000 dogs and 10,000 cats enrolled in the MARS PETCARE BIOBANK ™ initiative will be sequenced over the next 10 years.

Key Points: 
  • Genomes from 10,000 dogs and 10,000 cats enrolled in the MARS PETCARE BIOBANK ™ initiative will be sequenced over the next 10 years.
  • Insights from the open access database can help advance individualized pet health care for future generations of dogs and cats.
  • Mars Petcare scientists will be analyzing data and publishing initial results for the scientific community throughout 2023 and beyond.
  • "Our latest initiative with the Broad Institute is hugely exciting when it comes to advancing preventive pet care.

Worldwide Nasopharyngeal Cancer Industry to 2028 - North America is the Fastest Growing Region - ResearchAndMarkets.com

Retrieved on: 
Friday, January 6, 2023
Pharmaceutical, Health, Oncology, EBRT, Hearing loss, Bone, Adenocarcinoma, MRI, Headache, IARC, Megasphaera, Woman, Tobacco, Severe acute respiratory syndrome coronavirus 2, MEA, American Institute, Initial, Squamous cell carcinoma, COVID-19, Organic, Pharynx, News, Immunotherapy, Brachytherapy, Research, Nasopharyngeal carcinoma, Growth, Patient, CT, Chemoradiotherapy, Weight loss, PET, Fatigue, Blurred, Hypoesthesia, Neck, Prevalence, Diagnosis, NPC, Cell, Dietary supplement, Pharmaceutical industry, Medical imaging, Marketing, Cancer

The symptoms of nasopharyngeal cancer include a lump in the neck, hearing loss, stuffiness, numbness, frequent headaches, fatigue, blurred, weight loss etc.

Key Points: 
  • The symptoms of nasopharyngeal cancer include a lump in the neck, hearing loss, stuffiness, numbness, frequent headaches, fatigue, blurred, weight loss etc.
  • According to the American Institute for Cancer Research estimates, Nasopharyngeal cancer is the 23rd most common cancer worldwide, and it is the 18th most commonly occurring cancer in men and the 22nd most commonly occurring cancer in women.
  • Thus, the high prevalence rate of nasopharyngeal cancer will increase the demands for effective drugs and therapies that will further lead to market growth.
  • The global nasopharyngeal cancer market is segmented based on cancer type, diagnosis method, and therapy.

Worldwide Micro Injection Molding Medical Devices Industry to 2027 - Players Include Biomerics, MTD Micro Molding, Kamek Precision Tools and PEXCO - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 3, 2023
Medical Devices, Health, Cancer, Ageing, Update, American Cancer Society, Kool-Aid, Death, GERD, Ear, Megasphaera, ACS, Degenerative disease, Interventions, Moyamoya disease, National Center for Health Research, Philippine Statistics Authority, Centers for Disease Control and Prevention timeline, National Center for Biotechnology Information, Risk, Huber loss, Growth, Patient, Cardiovascular disease, American Cancer Society Cancer Action Network, World Health Organization, Gastroesophageal reflux disease, Cervical cancer, Stomach cancer, Conditional sentence, Tinnitus, Prevalence, Diagnosis, PSA, Woman, Medical device, Dentistry, Medical imaging, Dietary supplement

The rising prevalence of gastrointestinal disorders requiring endoscopy surgeries and technical improvements in endoscopic devices are the key driving factor for the market's growth.

Key Points: 
  • The rising prevalence of gastrointestinal disorders requiring endoscopy surgeries and technical improvements in endoscopic devices are the key driving factor for the market's growth.
  • Thus, the increasing awareness regarding minimally invasive surgical procedures and the rising prevalence of chronic diseases are boosting the market's growth over the forecast period.
  • For instance, according to GLOBOCAN, 2020, 2,281,658 new cancer cases were diagnosed in the United States in 2020, with 612,390 fatalities.
  • Similarly, according to the American Cancer Society 2021, it is estimated that 250 new cases of cervical cancer will be diagnosed in 2021.

Hair Wig and Extension (Human Hair, Synthetic) Markets - Global Forecast to 2028: Rise in the Popularity of Prominent Celebrity and Social Media Influencers - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 15, 2022
Cosmetics, Retail, Fashion, Woman, National Center for Medical Readiness, Hair loss, Prevalence, Megasphaera, Marketing, International Society, Hair, Wig, Beauty, Competition, National Center for Biotechnology Information, Growth, Social media, Market share, Cosmetics, Beauty salon, Toy, Extension

Due to the problems with hair loss or damage, Asia-Pacific accounts for controlling share in global market for hair wigs and extensions.

Key Points: 
  • Due to the problems with hair loss or damage, Asia-Pacific accounts for controlling share in global market for hair wigs and extensions.
  • The prominence of celebrities and social media influencers is one of the major factors fueling the rise of the hair wig and extension industry.
  • The rising popularity of using mannequin among the fashion outlets is positively influencing the growth of the hair wig and extension market.
  • Company Profiles: Detailed analysis of the major companies present in the global Hair Wig and Extension market.

Global Diabetic Retinopathy Market Report to 2027 - Featuring Bayer, Alimera Sciences, Novartis and Pfizer Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 22, 2022
Health, Pharmaceutical, Prevalence, Blood, Diabetic retinopathy, Macular edema, Investment, Membrane, Severe cognitive impairment, Retina, Glaucoma, Retinal detachment, United Nations, National Center for Integrative Biomedical Informatics, Laser, Ageing, Insulin, Diabetes, National Center for Biotechnology Information, Housing, Retinal vessel analysis, Megasphaera, Transport, Eye, Developing country, Patient, Medical device, Pharmaceutical industry, Health insurance, Healthcare

The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period.

Key Points: 
  • The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period.
  • Impairment to blood vessels of the light-sensitive tissue of the retina is the main cause of diabetic retinopathy.
  • Diabetic retinopathy can also mutate to proliferative diabetic retinopathy, which is a more severe form of the disorder.
  • Non-proliferative diabetic retinopathy, NPDR, is a kind of diabetic retinopathy in which symptoms are minimal or absent.